291 related articles for article (PubMed ID: 8544175)
21. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
22. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
Clifford JL; Petkovich M; Chambon P; Lotan R
Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
[TBL] [Abstract][Full Text] [Related]
23. Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity.
Kikuchi K; Hibi S; Yoshimura H; Tokuhara N; Tai K; Hida T; Yamauchi T; Nagai M
J Med Chem; 2000 Feb; 43(3):409-19. PubMed ID: 10669568
[TBL] [Abstract][Full Text] [Related]
24. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
25. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
26. 6'-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands.
Graupner G; Malle G; Maignan J; Lang G; Pruniéras M; Pfahl M
Biochem Biophys Res Commun; 1991 Sep; 179(3):1554-61. PubMed ID: 1656958
[TBL] [Abstract][Full Text] [Related]
27. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta.
Crettaz M; Baron A; Siegenthaler G; Hunziker W
Biochem J; 1990 Dec; 272(2):391-7. PubMed ID: 2176462
[TBL] [Abstract][Full Text] [Related]
28. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment.
Taneja R; Rochette-Egly C; Plassat JL; Penna L; Gaub MP; Chambon P
EMBO J; 1997 Nov; 16(21):6452-65. PubMed ID: 9351827
[TBL] [Abstract][Full Text] [Related]
30. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.
Boylan JF; Lohnes D; Taneja R; Chambon P; Gudas LJ
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9601-5. PubMed ID: 8105479
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
32. Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types.
Taneja R; Bouillet P; Boylan JF; Gaub MP; Roy B; Gudas LJ; Chambon P
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7854-8. PubMed ID: 7644503
[TBL] [Abstract][Full Text] [Related]
33. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
Alvarez R; Checa M; Brun S; Viñas O; Mampel T; Iglesias R; Giralt M; Villarroya F
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):91-7. PubMed ID: 10600643
[TBL] [Abstract][Full Text] [Related]
34. Regulation of differentiating pig preadipocytes by retinoic acid.
Brandebourg TD; Hu CY
J Anim Sci; 2005 Jan; 83(1):98-107. PubMed ID: 15583048
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
Wan YJ; Cai Y; Magee TR
Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
[TBL] [Abstract][Full Text] [Related]
36. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma.
Bernard BA; Bernardon JM; Delescluse C; Martin B; Lenoir MC; Maignan J; Charpentier B; Pilgrim WR; Reichert U; Shroot B
Biochem Biophys Res Commun; 1992 Jul; 186(2):977-83. PubMed ID: 1323296
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
Zhuang Y; Faria TN; Chambon P; Gudas LJ
Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
[TBL] [Abstract][Full Text] [Related]
38. Molecular and metabolic retinoid pathways in the human ocular surface.
Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
[TBL] [Abstract][Full Text] [Related]
39. Biochemical characteristics and differentiating activity of 4-oxo analogs of retinoic acid.
Sani BP; Venepally P; Zhang XK; Hill DL; Shealy YF
Anticancer Res; 1996; 16(3A):1177-81. PubMed ID: 8702232
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models.
Chen S; Ostrowski J; Whiting G; Roalsvig T; Hammer L; Currier SJ; Honeyman J; Kwasniewski B; Yu KL; Sterzycki R
J Invest Dermatol; 1995 May; 104(5):779-83. PubMed ID: 7738355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
